These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


167 related items for PubMed ID: 7065035

  • 1. Regression of pituitary microadenoma during and following bromocriptine therapy: persistent defect in prolactin regulation before and throughout pregnancy.
    Yuen BH, Cannon W, Sy L, Booth J, Burch P.
    Am J Obstet Gynecol; 1982 Mar 15; 142(6 Pt 1):634-9. PubMed ID: 7065035
    [Abstract] [Full Text] [Related]

  • 2. Normal and abnormal prolactin levels during human pregnancy. Lack of influence on fetoplacental endocrine function.
    Andersen AN, Pedersen H, Westergaard JG, Schiøler V, Arends J.
    Acta Obstet Gynecol Scand; 1984 Mar 15; 63(2):145-8. PubMed ID: 6730928
    [Abstract] [Full Text] [Related]

  • 3. Prolactin and placental hormone levels during pregnancy in prolactinomas.
    Batrinos ML, Panitsa-Faflia C, Anapliotou M, Pitoulis S.
    Int J Fertil; 1981 Mar 15; 26(2):77-85. PubMed ID: 6114069
    [Abstract] [Full Text] [Related]

  • 4. Acute changes in serum prolactin concentration have no effect on the secretion of progesterone, estradiol, or chorionic gonadotropin during early pregnancy.
    Ranta T, Lehtovirta P, Stenman UH, Laatikainen T, Seppälä M.
    J Clin Endocrinol Metab; 1980 Sep 15; 51(3):544-7. PubMed ID: 7410533
    [Abstract] [Full Text] [Related]

  • 5. The effect of pregnancy and lactation on pituitary prolactin-secreting tumours.
    Zárate A, Canales ES, Alger M, Forsbach G.
    Acta Endocrinol (Copenh); 1979 Nov 15; 92(3):407-12. PubMed ID: 517046
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Effect of bromocriptine on the endocrine profile during pregnancy].
    Kubota T, Yaoi Y, Suzuki A, Nishi N, Saito M, Kumasaka T.
    Nihon Sanka Fujinka Gakkai Zasshi; 1982 Oct 15; 34(10):1675-83. PubMed ID: 7175275
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Conservative management of suspected prolactin secreting pituitary adenoma during pregnancy.
    Weinstein D, Yarkoni S, Schenker JG, Sahar A, Siew FP, Ben-David M, Polishuk WZ.
    Eur J Obstet Gynecol Reprod Biol; 1981 Apr 15; 11(5):305-12. PubMed ID: 7194821
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Regression of a prolactin-secreting pituitary tumor during long-term treatment with bromocriptine.
    Nillius SJ, Bergh T, Lundberg PO, Stahle J, Wide L.
    Fertil Steril; 1978 Dec 15; 30(6):710-2. PubMed ID: 729834
    [Abstract] [Full Text] [Related]

  • 17. A pregnancy in an acromegalic woman during bromocriptine treatment: effects on growth hormone and prolactin in the maternal, fetal, and amniotic compartments.
    Bigazzi M, Ronga R, Lancranjan I, Ferraro S, Branconi F, Buzzoni P, Martorana G, Scarselli GF, Del Pozo E.
    J Clin Endocrinol Metab; 1979 Jan 15; 48(1):9-12. PubMed ID: 422709
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.